Home > Boards > US Listed > Biotechs >

Sonnet BioTherapeutics Inc (SONN)

SONN RSS Feed
Add SONN Price Alert      Hide Sticky   Hide Intro
Moderator: mick
Search This Board: 
Last Post: 5/28/2020 1:01:48 AM - Followers: 46 - Board type: Free - Posts Today: 0





UNDER CONTRUCTION;
https://www.sonnetbio.com/



 

Sonnet Pipeline

Our clinical-stage pipeline comprises five cytokine-derived therapeutic candidates, with a lead compound, SON-080, ready to enter Phase 2 development.
 

Program Indications Discovery Preclinical Phase 1 Phase 2
 
SON-080 (low-dose IL-6) Chemotherapy Induced Peripheral Neuropathy
Discovery Phase complete
Pre-clinical Phase complete
Phase I Phase in progress
Phase II Phase not started
SON-081 (low dose IL-6) Diabetic Peripheral Neuropathy
Discovery Phase complete
Pre-clinical Phase complete
Phase I Phase in progress
Phase II Phase not started
FHAB PLATFORM
SON-1010 (IL12-FHAB) Undisclosed Solid Tumor
Discovery Phase complete
Pre-clinical Phase in progress
Phase I Phase not started
Phase II Phase not started
SON-1210 (IL15-FHAB-IL12) Undisclosed Solid Tumor
Discovery Phase complete
Pre-clinical Phase in progress
Phase I Phase not started
Phase II Phase not started
SON-2014 (GMcSF-FHAB-IL18) Early Stage Cancer
Discovery Phase in progress
Pre-clinical Phase not started
Phase I Phase not started
Phase II Phase not started
SON-3015 (Anti-IL6-FHAB-Anti-TGFβ) Tumor and Bone Metastases
 

A Modular Drug Development Platform

Our Fully Human Albumin Binding (FHAB) technology is the foundation of a modular, plug-and-play drug development platform with several distinct advantages:

  • Compatibility with many biologic drug classes, including interleukins, growth factors, peptides and vaccines
    Enhanced pharmacokinetics
    Targeted, directed activity for tumor selectivity
    Increased in vivo efficacy
    Single- or bi-specific mechanisms of action

  •  



https://finviz.com/quote.ashx?t=SONN&ty=c&ta=1&p=d
https://finviz.com/chart.ashx?t=SONN&ty=c&ta=1&p=d&s=l



Chanticleer Holdings Announces 1-for-26 Reverse Stock Split
Date : 03/31/2020 @ 4:07PM
Source : GlobeNewswire Inc.
Stock : Sonnet BioTherapeutics Inc (SONN)
Quote : 5.5727 0.4027 (7.79%) @ 10:17AM
Chanticleer Holdings Announces 1-for-26 Reverse Stock Split

==============================================================

http://ih.advfn.com/stock-market/NASDAQ/sonnet-biotherapeutics-SONN/stock-news/82132516/chanticleer-holdings-announces-1-for-26-reverse-st

Chanticleer Holdings, Inc. (Nasdaq: BURG)
(the “Company” or “Chanticleer”),
owner, operator and franchisor of multiple nationally-recognized restaurant brands,
today announced that it will effect a 1-for-26 reverse stock split of its outstanding common stock.

The reverse stock split will be effective for trading purposes as
of the commencement of trading on Thursday, April 2, 2020.

Chanticleer also announced today that the Nasdaq Stock Market has approved the continued listing of Sonnet BioTherapeutics Holdings, Inc.

on the Nasdaq Capital Market following its merger with Chanticleer, which is expected to close tomorrow,
April 1, 2020. As previously disclosed, in connection with the merger,

Chanticleer will spin off its restaurant operations.

Upon the closing of the merger,
Chanticleer will change its name to Sonnet BioTherapeutics Holdings, Inc.
and its common stock is expected to begin trading on the
Nasdaq Capital Market on Thursday, April 2, 2020 on a post
reverse stock split basis under the symbol “SONN”.

The reverse stock split is intended to increase the per share
trading price of Chanticleer common stock to satisfy the minimum
bid price requirement for continued listing on
The Nasdaq Capital Market after the completion of the merger.

Chanticleer’s common stock will continue to trade on
The Nasdaq Capital Market under the symbol “SONN” and under a
new CUSIP number 83548R105. As a result of the reverse stock split,

every 26 pre-split shares of common stock outstanding will become one share of common stock.

The par value of the common stock will remain unchanged at $0.0001 per share after the reverse stock split.

The reverse stock split will not change the authorized number of shares of the Company’s common stock.

The reverse stock split will affect all stockholders uniformly and
will not alter any stockholder’s percentage interest in the Company’s equity,
except to the extent that the reverse stock split results in some stockholders owning a fractional share.

No fractional shares will be issued in connection with the reverse split.

Stockholders who would otherwise be entitled to receive a fractional share will instead receive a cash payment based on today’s
closing price of the Company’s common stock as reported on Nasdaq.

The reverse split will also apply to common stock issuable upon the exercise of Chanticleer’s outstanding warrants and stock options,
with a proportionate adjustment to the exercise prices thereof,
and under the Company’s equity incentive plans.

The reverse stock split will reduce the number of shares of common
stock issued and outstanding from approximately 14.2 million to approximately 0.55 million (prior to the merger).

On March 18, 2020, the holders of a majority of the Company’s outstanding shares of common stock approved the reverse stock split
and gave the Company’s board of directors discretionary authority
to select a ratio for the split ranging from 1-for-2 to 1-for-40.

The board of directors approved the reverse stock split at a ratio of 1-for-26 on March 26, 2020.

As previously disclosed, the Company’s existing restaurant business, including its assets and liabilities, will be spun-off immediately
prior to the close of the merger into a newly created corporate entity.

This new entity will be named Amergent Hospitality Group
(“Amergent”) and will be wholly owned by Chanticleer’s shareholders owning common stock of record as of the close of business on Thursday,
March 26, 2020, the record date for the spin-off.

Securities Transfer Corporation is acting as the exchange agent
and transfer agent for the reverse stock split.

Stockholders holding their shares in book-entry form or in brokerage accounts need not take any action in connection with the reverse
stock split.
Beneficial holders are encouraged to contact their bank, broker or custodian with any procedural questions.

About Chanticleer Holdings, Inc.

Headquartered in Charlotte, NC, Chanticleer Holdings owns, operates,
and franchises fast, casual,
and full-service restaurant brands, including American Burger Company,

BGR – Burgers Grilled Right, Little Big Burger, Just Fresh, and Hooters. For more information, please visit:
http://www.chanticleerholdings.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the closing of the merger.

All statements pertaining to Chanticleer Holdings, Inc.’s expectations regarding future financial and/or operating results, potential for our tests and services and future revenues or growth in this press release constitute forward-looking statements.

Any statements that are not historical fact
(including, but not limited to, statements that contain words such
as “will,” “believes,” “plans,” “anticipates,” “expects,” “estimates”) should also be considered to be forward-looking statements.

Forward-looking statements involve risks and uncertainties discussed
in the Chanticleer Holdings, Inc.
Form 10-K for the year ended December 31, 2019, along with other
filings with the Securities and Exchange Commission.

These forward-looking statements speak only as of the date hereof.

Chanticleer Holdings, Inc. disclaims any obligation to update these forward-looking statements.

Chanticleer Holdings Investor Contact:

Jason Assad
678-570-6791
ja@chanticleerholdings.com

Sonnet BioTherapeutics

Alan Lada
617-221-8006
alada@soleburytrout.com



 *DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.





 
SONN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BURG News: Chanticleer Holdings Announces Merger S-4 Effective by SEC 02/14/2020 12:28:45 PM
BURG News: Chanticleer Holdings Announces Record Date for Special Meeting to Approve Proposed Business Combination 01/16/2020 08:30:10 AM
PostSubject
#1204   Sonnet BioTherapeuti (SONN) mick 05/28/20 01:01:48 AM
#1203   Give me that $50 NEWS. :-) LOVE*PINK 05/16/20 08:29:31 PM
#1202   Hi, how are you doing? elcheepo 05/15/20 09:02:57 PM
#1201   Hi SONN :-) CrazyMoney101 05/14/20 12:03:51 PM
#1200   Sonnet BioTherapeuti (SONN) mick 05/08/20 04:10:48 PM
#1199   SONN on watch alert m1999 04/27/20 09:00:57 PM
#1198   SONN looking to entry big m1999 04/27/20 09:00:42 PM
#1197   SON was in march $54.00++ PPS,WOWZA coming here m1999 04/27/20 09:00:12 PM
#1196   SONN 1000%% runner in few days m1999 04/27/20 08:59:19 PM
#1195   https://otcbb.swingtradebot.com/equities/SONN mick 04/25/20 01:23:09 PM
#1194   I think someone bought a big chunk of Kaad_g 04/23/20 09:09:42 AM
#1193   Now what happened ? elcheepo 04/22/20 04:45:57 PM
#1192   Sonnet BioTherapeuti (SONN), the gapper ????? nothing did mick 04/16/20 12:11:00 PM
#1191   big move up, big move down, mick 04/16/20 12:10:18 PM
#1190   What makes you say that? Price keeps going down anilLiAnCe 04/15/20 10:25:56 PM
#1189   THIS IS YOUR BEAUTIFUL DIP BUY HERE GUYS. TheMarketWizard 04/15/20 11:11:51 AM
#1188   I think this is a buy zone now. aidytrader 04/15/20 10:36:55 AM
#1187   Still a move to make here? wshswr48 04/15/20 09:00:01 AM
#1186   I have a theory Frontline19721 04/14/20 11:30:28 PM
#1185   Volcano...you are a perfect buddhu...figure that one out badshah 04/14/20 06:41:33 PM
#1184   SONN Delivers..... davidsson10 04/14/20 05:24:06 PM
#1180   I told you to sell today Volcano 04/14/20 04:28:56 PM
#1179   * * $SONN Video Chart 04-14-2020 * * ClayTrader 04/14/20 04:16:07 PM
#1178   I can’t believe I am, but I am. CopperGold 04/14/20 04:02:19 PM
#1177   Yup. Bingo. ClarkKant 04/14/20 03:24:50 PM
#1176   Anyone holding overnight after what happened with that ClarkKant 04/14/20 03:23:35 PM
#1175   going back up Ski22 04/14/20 02:03:09 PM
#1174   Weeee looked away for a second. I'm on ManBearPig-ish 04/14/20 01:20:21 PM
#1172   Nice opportunity to ADD LOVE*PINK 04/14/20 12:53:23 PM
#1171   Last company release showed 2.1 mill elcheepo 04/14/20 11:38:42 AM
#1170   By the looks of things the old one ManBearPig-ish 04/14/20 11:20:14 AM
#1169   Finviz has 9mill ish Awl416 04/14/20 11:10:51 AM
#1167   based on what OS? elcheepo 04/14/20 10:48:40 AM
#1166   Trading 30 times volume after an hour? Hmmm ManBearPig-ish 04/14/20 10:39:33 AM
#1165   da sheet; https://finviz.com/quote.ashx?t=SONN&ty=c&ta=1&p=d mick 04/14/20 10:39:03 AM
#1164   How did anyone get shares? This has no ManBearPig-ish 04/14/20 10:29:33 AM
#1163   sonn monster move, mick 04/14/20 10:21:14 AM
#1162   Now we will seeeee $20+ Golden_Cross 04/14/20 10:19:39 AM
#1161   Very Nice a Monster move powerbattles 04/14/20 10:19:07 AM
#1160   Sonnet BioTherapeuti (SONN) mick 04/14/20 10:18:05 AM
#1159   Could see a 250% gainer here today elcheepo 04/14/20 10:17:56 AM
#1158   nice pre-market mover; into early morning pps. wow mick 04/14/20 10:17:45 AM
#1157   I'm too late. jamesclopez00 04/14/20 10:16:31 AM
#1156   This play is done for now Sold out all Volcano 04/14/20 10:16:06 AM
#1155   If you can pick a good CV stock Easy Volcano 04/14/20 10:14:04 AM
#1154   Who wants to play pink if big board Volcano 04/14/20 10:12:43 AM
#1153   This shit is crazie CyrusDaVirus 04/14/20 10:07:48 AM
#1152   CONGRATS! powerbattles 04/14/20 10:06:06 AM
#1151   $15.00 target reached! ;-) jackson73 04/14/20 10:03:05 AM
#1150   Easy 150% profit today CAP$ is the next runner Volcano 04/14/20 10:02:16 AM
PostSubject